NEW YORK (360Dx) – Point-of-care platforms are broadening access to the fast-growing area of testing for sexually transmitted infectious (STI) diseases.

Developers of these platforms and use of their STI assays in urgent care centers and physician clinics say that the tests provide greater convenience, more privacy, and quicker results than laboratory tests — benefits that are especially important for public health and broader adoption.

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.